Since its opening, September 1, the dynamics of the countryside is rather good for people over 65 years old. On the other hand, those with comorbidities are not at the rendezvous.
by and
With six months of offset, the CVIV-19 reminder campaign is built in the mirror of that started in late December: a slow start with the hope of acceleration. If it seems engaged on a good way in people over the age of 65, she still patines with those with comorbidities. But the biggest work is yet to come, as the people will grow eligible for this recall. A closely monitored situation while the incidence rates go back to France, particularly pushing the authorities to impose the port of the mask again in the schools of thirty-nine additional departments.
The most restrictive eligibility criterion is, indeed, to have completed its vaccination scheme at least six months ago. However, we remember, the vaccine target has expanded very slowly with the dusk beginnings of the campaign. A delay in ignition related to the DRIVING DRIVES DOSS OF VACCINES, then, in the city cabinets, at the stop at the Astrazeneca vaccine. At 1 May, only 7 million people had received their two doses. They can now request additional injection of messenger RNA vaccine to strengthen the response of their immune system against SARS-COV-2.
Six months later, at $ 1, some 3 million people had recalled, 43% of the eligible population, mainly people aged 65 and over living at home ( 69%). In accommodation facilities for dependent elderly people (EHPAD), the dynamics is also good (74%). But membership is more limited in children under 65 suffering from comorbidities (19%). “It’s hard to explain”, recognizes Jacques Battistoni, president of the MG France union, who has the impression that “younger patients with comorbidities have no doubt less aware of the danger.” In harm, according to this general practitioner.
“A teaching exercise a little subtle”
“For the moment, it is clearly below the final goal, recognizes Alain Fischer, Chairman of the Vaccine Strategy Orientation Board (COSV). To ensure optimal protection for fragile people, it would be necessary to tender towards A vaccinal recall cover of the order of 90% or more. “It points, however, a difficulty: that of the” double speech “to hold, when one should explain that the two-dose vaccination scheme is effective but a reminder is still necessary. This is “a teaching exercise a little subtle”, he admits.
You still have 73.03% of this article to read. The rest is reserved for subscribers.